This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC 2022 Programme

Subpage Hero

.

Loading

Safer prescribing & monitoring of DOACs in Atrial Fibrillation

13 May 2022
Showcase

The significance of calculating CrCl when deciding on DOAC dose in AF has been highlighted many times in recent years, however, we still have issues with getting this right in practice. In Otley PCN, following the MHRA alert June 2020, a service improvement project was designed to improve the initiation and monitoring of DOACs for AF through implementation of a template embedded in the GP IT system. The aim was that by increasing adherence to Amber drug monitoring, this in turn would lead to more accurate dosing and safer prescribing overall.

Learning outcomes:

- The importance of appropriate monitoring of DOACs in AF and the impact that has on correct dosing.
- Greater awareness of how issues around monitoring can be addressed in general practice, potentially through use of a template.
- How implementation of such a template can support achieving the new IIF indicators, particularly SMR-03.

 

Speakers
Hadeel Mohamed, Lead Clinical Pharmacist - Otley PCN

Partners

Lead Education Partner

  • CPPE
  • Morph

 

Education Partner

  • APTUK
  • BOPA
  • BPNG
  • CMHP
  • Health Education England

 

Education Partner

  • HIVPA
  • UKRPG
  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC

 

Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS

 

Education Partner

  • Soar Beyond
  • NHCA
  • UKBPA
  • UKCPA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS

 

Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber

 

Nominated Charity

  • Pharmacist Support

 

Newsletter Sign Up